Literature DB >> 16792617

Idiopathic non-histaminergic angio-oedema after routine extubation successfully treated with fresh frozen plasma.

D Franzen1, T Ursprung, B Wuthrich, A Reber.   

Abstract

Non-allergic angio-oedema is a potentially life-threatening condition typically seen in patients with hereditary or acquired angio-oedema caused by C1 inhibitor deficiency or an adverse drug reaction to angiotensin converting enzyme inhibitors. We report a case of sudden angio-oedema in a patient who developed severe swelling of the tongue and neck after routine extubation requiring resuscitative re-intubation. The oedema was refractory to conventional allergy treatment. Shortly thereafter, the patient was treated with fresh frozen plasma, and within a few hours his condition improved, allowing extubation. Familial history and exposure to potentially angio-oedema causative drugs were not evident. The serum complement status was normal, and no IgE sensitisation was detected. We therefore concluded that the patient was suffering from idiopathic non-histaminergic angio-oedema. To our knowledge, this is the first reported case of an acute, life-threatening attack of idiopathic non-histaminergic angio-oedema that was successfully treated with fresh frozen plasma.

Entities:  

Mesh:

Year:  2006        PMID: 16792617     DOI: 10.1111/j.1365-2044.2006.04648.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  4 in total

1.  [Angioedema caused by C1-esterase inhibitor deficiency or ACE inhibitors?].

Authors:  M G Dehne; M Zimmer; R Deisz; K Bork
Journal:  Anaesthesist       Date:  2007-04       Impact factor: 1.041

2.  Fresh frozen plasma in the treatment of ACE inhibitor-induced angioedema.

Authors:  Michael Stewart; Ray McGlone
Journal:  BMJ Case Rep       Date:  2012-08-24

3.  Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials.

Authors:  Martin Christian Bucher; Tatjana Petkovic; Arthur Helbling; Urs Christian Steiner
Journal:  Clin Transl Allergy       Date:  2017-08-31       Impact factor: 5.871

4.  Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients.

Authors:  Enrico Brunetta; Dana Shiffer; Marco Folci; Maria I S Achenza; Francesca Puggioni; Enrico Heffler; Raffaello Furlan; Giorgio W Canonica
Journal:  Case Reports Immunol       Date:  2018-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.